- Home
- NRDS vs TLRY Comparison
NRDS vs TLRY Comparison
Compare NRDS & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRDS | TLRY |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 720.4M | 688.9M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NRDS | TLRY |
|---|---|---|
| Price | $8.36 | $4.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $15.00 | ★ $72.33 |
| AVG Volume (30 Days) | 809.0K | ★ 3.2M |
| Earning Date | 05-06-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 68.42 | N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $836,600,000.00 | N/A |
| Revenue This Year | $10.13 | $8.79 |
| Revenue Next Year | $7.11 | $19.98 |
| P/E Ratio | $29.31 | ★ N/A |
| Revenue Growth | ★ 21.67 | N/A |
| 52 Week Low | $7.33 | $0.36 |
| 52 Week High | $16.24 | $15.70 |
Technical Indicators
Market Signals| Indicator | NRDS | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 33.07 |
| Support Level | $7.82 | $1.12 |
| Resistance Level | $8.81 | $5.71 |
| Average True Range (ATR) | 0.31 | 0.28 |
| MACD | 0.10 | -0.00 |
| Stochastic Oscillator | 54.27 | 1.60 |
Price Performance
Historical ComparisonAbout NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.